Isabelle Demeestere, MD, PhD, Université Libre de Bruxelles (ULB), Brussels, Belgium, emphasizes the critical role oncologists play in discussing potential gonadotoxicity with patients. Collaboration with fertility centers is essential for offering fertility preservation options and long-term management of reproductive health, quality of life, and sexuality. Oncologists should be equipped with sufficient knowledge to inform patients about the impact of treatments on fertility, delay in pregnancy, and referral to specialists for oncofertility counseling. This approach is recommended by clinical guidelines, ensuring comprehensive patient care. This interview took place at the European Society for Medical Oncology (ESMO) 2024 Congress in Barcelona, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
